Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials
Anna‐Maria Hoffmann‐Vold, Elizabeth R. Volkmann, Yannick Allanore, Shervin Assassi, Jeska K de Vries‐Bouwstra, Vanessa Smith, Inga Tschoepe, Lazaro Loaiza, Madhu Kanakapura, Oliver Distler
Topics & Concepts
NintedanibMedicineIdiopathic pulmonary fibrosisInternal medicineTolerabilityPlaceboInterstitial lung diseaseAdverse effectNauseaGastroenterologyLungPathologyAlternative medicineSystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments